Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis

Gastrointestinal Endoscopy

Volumn 56, Issue 1, 2002, Pages 40-47

  Siqueira, Eduardo ^a,b   Schoen, Robert E ^a,b   Silverman, William ^a,b   Martini, John ^a,b   Rabinovitz, Mordechai ^a,b   Weissfeld, Joel L ^a,b   Elmaagd, Kareem Abu ^a,b   Madariaga, Juan R ^a,b   Slivka, Adam ^a,b,c  

^a University of Pittsburgh ^*

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c PUH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; BILE DUCT CARCINOMA; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE MARKER; ENTERITIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAHEPATIC BILE DUCT; MAJOR CLINICAL STUDY; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; BILE DUCT TUMOR; CYTOLOGY; SCLEROSING CHOLANGITIS;

ADULT; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; CYTOLOGICAL TECHNIQUES; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0036637247     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2002.125105     Document Type: Article

References (50)

1. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Eng J Med 1995;332:924-33.
2. Ueno Y, Larusso NF. Primary sclerosing cholangitis. J Gastroenterol 1994;29:531-43.
3. Abu-Elmaagd KM, Malinchok M, Dickson ER, Fung JJ, Murtaugh PA, Langworthy AL, et al. Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet 1993;177:335-44.
4. Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL. Liver transplantation for sclerosing cholangitis. Hepatology 1995;22:451-7.
5. Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westably D, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991;100:1710-7.
6. Ricci P, Therneau TM, Malinchok M, Benson JT, Petz JL, Klintmalm GB, et al. A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease. Hepatology 1997;25:672-7.
7. Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996;38:610-5.
8. Larusso NF, Wiesner RH, Ludwig J, Marty RL, Beaver SJ, Zinsmeister AR. Prospective trial of penicillamine in primary sclerosing cholangitis. Gastroenterology 1988;95:1036-42.
9. Knechtle SJ, D'Alessandro AM, Pirsch JD, Belzer FO, Kalayoglu M. Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery 1995;118:615-20.
10. Nashan B, Schlitt HJ, Tusch G, Oldhafer KJ, Ringe B, Wagner S, et al. Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation. Hepatology 1996;23:1105-11.
11. Abu-Elmaagd KM, Selby R, Iwatsuki S, Fung J, Tzakis A, Todo S, et al. Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. Transplant Proc 1993;25:1124-5.
12. Goss JA, Shackleton CR, Farmer DG, Arnaout WS, Seu P, Markowitz JS, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg 1997;225:472-83.
13. Bergquist A, Glaumann H, Persson B, Broome U. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 1998;27:311-6.
14. Van Laethem JL, Devihre J, Bourgeois N, Love J, Gelin M, Cremer M, et al. Cholangiographic findings in deteriorating primary sclerosing cholangitis. Endoscopy 1995;27:223-8.
15. Miros M, Kerlin P, Walker N, Harper J, Lynch S, Strong R. Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation. Gut 1991;32:1369-73.
16. Campbell WL, Ferris JV, Holbart BL, Thaete FL, Baron RL. Biliary tract carcinoma complicating primary sclerosing cholangitis: Evaluation with CT, cholangiography US and MR imaging. Radiology 1998;207:41-50.
17. Delcore R, Eisenach JB, Payne KM, Bhatia P, Forster J. Risk of occult carcinomas in patients undergoing orthotopic liver transplantation for end-stage liver disease secondary to primary sclerosing cholangitis. Transplant Proc 1993;25:1883-4.
18. Sherlock S. Primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune cholangitis. Clin Liv Dis 2000;4:97-121.
19. Ramage JK, Donaghy A, Farrant JM, Iorns R, Williams R. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1995;108:865-9.
20. Fisher A, Theise ND, Min A, Mor E, Emre S, Pearl A, et al. CA 19-9 does not predict cholangiocarcinoma in patients with primary sclerosing cholangitis undergoing liver transplantation. Liver Transplant Surg 1995;1:94-8.
21. Nichols JC, Gores GJ, Larusso N, Wiesner RH, Nagomey DM, Ritts REJ. Diagnostic role of serum CAl 9-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc 1993;68:874-9.
22. Chalasani N, Baluyut A, Ismail A, Zaman A, Sood G, Ghalib R, et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology 2000;31:7-11.
23. Ferrari APJ, Lichtenstein DR, Slivka A, Chang C, Carr-Locke DL. Brush cytology during ERCP for the diagnosis of biliary and pancreatic malignancies. Gastrointest Endosc 1994;40:140-5.
24. Kurzawinski TR, Deery A, Dooley JS, Dick R, Hobbs KEF, Davidson BR. A prospective study of biliary cytology in 100 patients with bile duct strictures. Hepatology 1993;18:1399-403.
25. Lee JG, Leung JW. Tissue sampling at endoscopic retrograde cholangiopancreatography in suspected pancreatic cancer. Gastrointest Endosc Clin N Am 1998;8:221-33.
26. Ponsioen CY, Vrouenraets SM, Van Milligen De Wit AW, Sturm P, Tascilar M, Offerhaus GJ, et al. Value of brush cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy 1999;31:305-9.
27. Greiner M, Pfeiffer D, Smith RD. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Veterinary Med 2000;45:23-41.
28. Henderson AR. Assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis. Ann Clin Biochem 1993;30:521-39.
29. Casella G. Refining binomial confidence intervals. Can J Statistics 1987;14:113-29.
30. Mor E, Schwartz ME, Sheiner P, Hytiroglou P, Katz E, Miller CM. Incidental cholangiocarcinoma associated with primary sclerosing cholangitis in a patient undergoing liver transplantation: strategy for management. Transplant Sci 1993;3:132-4.
31. Muiesan P, Shanmugan RP, Devlin J, Rela M, Heaton ND, Saxena R, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. Transplant Proc 1994;26:3574-6.
32. Ponchon T, Gagnon P, Berger F, Labadie M, Liaras A, Chavaillon A, et al. Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: results of a prospective study. Gastrointest Endosc 1995;42:565-72.
33. Rabinovitz M, Zajko AB, Hassanein T, Shetty B, Bron KM, Schade RR, et al. Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: a study in 65 patients with bile duct strictures. Hepatology 1990;12:747-52.
34. Pugliese V, Conio M, Nicol G, Saccomanno S, Gatteschi B. Endoscopic retrograde forceps biopsy and brush cytology of biliary strictures: a prospective study. Gastrointest Endosc 1995;42:520-6.
35. Howell DA, Beveridge RP, Bosco J, Jones M. Endoscopic needle aspiration biopsy at ERCP in the diagnosis of biliary strictures. Gastrointest Endosc 1992;38:531-5.
36. Schoefi R, Haefner M, Wrba F, Pfeffel F, Stain C, Poetzi R, et al. Forceps biopsy and brush cytology during endoscopic retrograde cholangiopancreatography for the diagnosis of biliary stenoses. Scand J Gastroenterol 1997;32:363-8.
37. Foutch PG, Kerr DM, Harlan JR, Kummet TD. A prospective, controlled analysis of endoscopic cytotechniques for diagnosis of malignant biliary strictures. Am J Gastroenterol 1991;86:577-80.
38. Lee JG, Leung JW, Baillie J, Layfield LJ, Cotton PB. Benign, dysplastic, or malignant-making sense of endoscopic bile duct brush cytology: results in 149 consecutive patients. Am J Gastroenterol 1995;90:722-6.
39. Steinberg W. The clinical utility of the CA 19-9 tumor-associated antigen. Am J Gastroenterol 1990;85:350-4.
40. Nakeeb A, Lipsett PA, Lillemoe KD, Fox-Talbot MK, Coleman J, Cameron JL, et al. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma. Am J Surg 1996;171:147-53.
41. Su CH, Shyr YM, Lui WY, Peng FK. Hepatolithiasis associated with cholangiocarcinoma. Br J Surg 1997;84:969-73.
42. Rogers SA, Podolsky DK. Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis: an analysis of the serological marker CA19-9. Hepatology 1994;19:543-5.
43. Rosen CB, Nagorney DM. Cholangiocarcinoma complicating primary sclerosing cholangitis. Semin Liver Dis 1991;11:26-30.
44. Van Leeuwen DJ, Reeders W. Primary sclerosing cholangitis and cholangiocarcinoma as a diagnostic and therapeutic dilemma. Ann One 1999;10:89-93.
45. Marcos-Alvarez A, Jenkins RL. Cholangiocarcinoma. Surg Oncol Clin North Am 1996;5:301-15.
46. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar and distal tumors. Ann Surg 1996;224:463-75.
47. Klempnauer J, Ridder GJ, Werner M, Weimann A, Pichlmayr R. What constitutes long term survival after surgery for hilar cholangiocarcinoma? Cancer 1997;79:26-34.
48. Herbener T, Zajko AB, Koneru B, Bron KM, Campbell WL. Recurrent cholangiocarcinoma in the biliary tree after liver transplantation. Radiology 1998;169:641-2.
49. Goldstein RM, Stone M, Tillery W, Senzer N, Levy M, Husberg BS, et al. Is liver transplantation indicated for cholangiocarcinoma? Am J Surg 1993;166:768-72.
50. Stueber AC, Marino IR, Iwatsuki S, Starzl TE. Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation. Int Surg 1989;74:1-3.